3 ZELTIQ Aesthetics Analyst Ratings, Earnings, Dividends and Insider Trades | $ZLTQ | NASDAQ:ZLTQ | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact ZELTIQ Aesthetics Company Profile (NASDAQ:ZLTQ) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for ZELTIQ Aesthetics (NASDAQ:ZLTQ) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)Consensus Rating:Buy (Score: 2.71)Consensus Price Target: $22.30 (24.93% upside) Analysts' Ratings History for ZELTIQ Aesthetics (NASDAQ:ZLTQ) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/21/2014Leerink SwannInitiated CoverageOutperform$26.00View 1/21/2014Maxim GroupBoost Price TargetBuy$16.00 -> $25.00View 1/14/2014Goldman SachsDowngradeBuy -> Neutral$19.00 -> $21.00View 12/31/2013ZacksDowngradeOutperform -> Neutral$19.80View 12/20/2013Canaccord GenuityBoost Price TargetBuy$16.00 -> $22.00View 11/21/2013Cantor FitzgeraldInitiated CoverageBuy$20.00View 10/31/2013Canaccord GenuityBoost Price TargetBuy$13.00 -> $16.00View 10/14/2013Goldman SachsUpgradeNeutral -> Buy$8.40 -> $12.00View 10/11/2013ZacksUpgradeNeutral -> Outperform$9.80View 9/24/2013Canaccord GenuityBoost Price TargetBuy$9.50 -> $13.00View 8/1/2013Canaccord GenuityBoost Price Target$6.00 -> $9.00View 7/25/2013William BlairUpgradeMarket Perform -> OutperformView 5/9/2013Maxim GroupInitiated CoverageBuy$7.00View 3/13/2013Canaccord GenuityLower Price TargetBuy$7.50 -> $6.00View 3/13/2013Goldman SachsLower Price Target$4.60 -> $4.50View 1/17/2013Canaccord GenuityReiterated RatingBuy$7.50View 1/7/2013Goldman SachsLower Price Target$4.60View 8/27/2012Goldman SachsLower Price TargetNeutral$6.00 -> $5.80View 8/1/2012Goldman SachsBoost Price TargetNeutral$5.50 -> $6.00View 8/1/2012Canaccord GenuityReiterated RatingBuyView 7/24/2012William BlairDowngradeOutperform -> Market PerformView 5/2/2012Canaccord GenuityReiterated RatingBuyView 3/9/2012Canaccord GenuityInitiated CoverageBuy$10.00View (Data available from 3/9/2012 forward) Earnings History for ZELTIQ Aesthetics (NASDAQ:ZLTQ)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/25/2014Q413($0.12)($0.15)$33.28 million$35.80 millionViewN/AView 10/30/2013Q313($0.19)($0.08)$21.30 million$29.50 millionViewN/AView 11/7/2012Q312($0.22)($0.15)$20.62 million$17.90 millionViewN/AView (Data available from 1/1/2011 forward) Dividend History for ZELTIQ Aesthetics (NASDAQ:ZLTQ)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for ZELTIQ Aesthetics (NASDAQ:ZLTQ)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare3/4/2014Kevin OboyleDirectorSell15,000$19.31$289,650.00View 1/21/2014Jean Georgemajor shareholderSell31,080$22.62$703,029.60View 1/17/2014Carl LammVPSell11,740$23.39$274,598.60View 11/18/2013Carl LammVPSell2,347$15.41$36,167.27View 11/14/2013Andrew SchiffDirectorSell575,000$12.22$7,026,500.00View 10/4/2013Carl LammVPSell1,624$9.00$14,616.00View 6/17/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View 5/21/2013Sergio GarciaVPSell7,688$5.00$38,440.00View 4/29/2013Keith J SullivanSVPBuy15,000$4.67$70,050.00View 4/23/2013Kristine N TatsutaniSVPSell18,540$5.80$107,532.00View 8/7/2012Bryan E RobertsDirectorBuy685,000$5.00$3,425,000.00View 8/6/2012Bryan E RobertsDirectorBuy60,000$4.72$283,200.00View (Data available from 1/1/2013 forward) About ZELTIQ Aesthetics Zeltiq Aesthetics, Inc. operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. It develops Cryolipolysis, a technology that enables the reduction of fat tissue near nerves, muscle, and bones. The Company develops a non-invasive technology for aesthetic applications and plastic surgery. Its product is used as a skin cooling device to minimize pain and thermal injury during laser and dermatological treatments. Headlines: (2/25) ZELTIQ Aesthetics Announces Fourth Quarter and Full Year 2013 Financial Results (2/10) ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2013 Financial Results to be Held on ... (2/24) RDInvesting Provides Investors with Free In-Depth Equity Reports on MTSN, TXT, XNPT and ZLTQ Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Equipment & Supplies Sub-Industry: Health Care Equipment Exchange: NASDAQ Symbol: ZLTQ CUSIP: 98933Q10 Key Metrics: Previous Close: $17.8750 Day Moving Average: $19.9921200 Day Moving Average: $14.9078 P/E Ratio: N/AP/E Growth: N/AMarket Cap: $664.2MCurrent Quarter EPS Consensus Estimate: $-0.36 EPS Additional Links: View ZLTQ on Google FinanceView ZLTQ on Yahoo FinanceView ZLTQ's Company Profile on ReutersSearch for ZELTIQ Aesthetics Inc. on Google ZELTIQ Aesthetics (NASDAQ:ZLTQ) Chart for Sunday, March, 9, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.